Literature DB >> 1549844

Energy charge as an indication of liver viability. A comparison of changes in livers that remained intact with those subjected to autografting.

R Hickman1, C Rose-Innes, M Tyler, M Bracher, Z Lotz, J Fourie.   

Abstract

As efforts to assess the viability of liver grafts continue, the recent description of noninvasive measurement by fluorimetry or magnetic resonance spectrometry of adenine nucleotides has brought energy charge into focus again as an index of viability. Many previous studies have been conducted in human donor livers that have clinical relevance but which cannot be standardized, or in rats in which the hepatic artery is not anastomosed. In the present study, pig livers were definitively rendered ischemic for 1 or 2 hr. In one group the livers were then revascularized (intact) while in the other, the livers were removed during the final 20-30 min of the ischemic period and were subjected to autograft. There was a marked difference in survival between the intact and the autograft groups. One hour of ischemia in the intact group was associated with survival comparable to that of autograft controls (8-100 days); 2 hr of ischemia caused shortened survival, ranging from 2 to 18 days. In the recipients of autografts, survival after 1 hr of ischemia ranged from 3 to 16 days; after 2 hr of ischemia no autograft recipient survived overnight. The energy charge returned to the preoperative level after 2 hr of ischemia in both intact and autograft groups. The concentrations remained depressed after 2 hr of ischemia in autografted animals, thus being associated with survival. However, the patterns of total adenine nucleotide and adenosine triphosphate were not always similar to those of energy charge. The concentrations of aspartate aminotransferase were similarly elevated in all ischemic groups irrespective of duration or subsequent survival. There was, however, a close association between euglobulin lysis times (ELT) and survival. In the autograft recipients of livers subjected to 2 hr of ischemia that did not survive overnight the ELT remained significantly shortened. It is concluded that adenine nucleotide metabolism is important as an index of viability, but that concentrations of total and individual adenine nucleotides and the energy change all need to be computed. There does, however, appear to be an absolute relationship between survival and euglobulin lysis time that would be clinically useful in patients undergoing liver transplantation or hepatic vascular exclusion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1549844     DOI: 10.1097/00007890-199203000-00009

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Can the rat donor liver tolerate prolonged warm ischemia?

Authors:  Ji-Qi Yan; Hong-Wei Li; Wei-Yao Cai; Ming-Jun Zhang; Wei-Ping Yang
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

2.  Current status and recent advances of liver transplantation from donation after cardiac death.

Authors:  M Thamara Pr Perera; Simon R Bramhall
Journal:  World J Gastrointest Surg       Date:  2011-11-27

3.  Safe upper limit of intermittent hepatic inflow occlusion for liver resection in cirrhotic rats.

Authors:  D X Lei; C H Peng; S Y Peng; X C Jiang; Y L Wu; H W Shen
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

4.  Evaluating the effects of extended cold ischemia on interstitial metabolite in grafts in kidney transplantation using microdialysis.

Authors:  Hamidreza Fonouni; Parvin Jarahian; Morva Tahmasbi Rad; Mohammad Golriz; Alireza Faridar; Majid Esmaeilzadeh; Mohammadreza Hafezi; Stephan Macher-Goeppinger; Thomas Longerich; Berk Orakcioglu; Oliver W Sakowitz; Camelia Garoussi; Arianeb Mehrabi
Journal:  Langenbecks Arch Surg       Date:  2012-10-16       Impact factor: 3.445

5.  Microdialysis monitoring for evaluation of the influence exerted by pneumoperitoneum on the kidney: an experimental study.

Authors:  T Iwata; A Gilispie; C Jorns; S Yamamoto; G Nowak; B-G Ericzon
Journal:  Surg Endosc       Date:  2007-08-19       Impact factor: 4.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.